Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Re (RMAX) Cash & Equivalents (2016 - 2025)

Re (RMAX) has disclosed Cash & Equivalents for 14 consecutive years, with $118.7 million as the latest value for Q4 2025.

  • Quarterly Cash & Equivalents rose 22.89% to $118.7 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $118.7 million through Dec 2025, up 22.89% year-over-year, with the annual reading at $118.7 million for FY2025, 22.89% up from the prior year.
  • Cash & Equivalents for Q4 2025 was $118.7 million at Re, up from $107.5 million in the prior quarter.
  • The five-year high for Cash & Equivalents was $126.3 million in Q4 2021, with the low at $66.1 million in Q2 2024.
  • Average Cash & Equivalents over 5 years is $101.1 million, with a median of $99.7 million recorded in 2021.
  • The sharpest move saw Cash & Equivalents tumbled 31.72% in 2024, then skyrocketed 42.76% in 2025.
  • Over 5 years, Cash & Equivalents stood at $126.3 million in 2021, then decreased by 13.94% to $108.7 million in 2022, then dropped by 23.96% to $82.6 million in 2023, then increased by 16.94% to $96.6 million in 2024, then rose by 22.89% to $118.7 million in 2025.
  • According to Business Quant data, Cash & Equivalents over the past three periods came in at $118.7 million, $107.5 million, and $94.3 million for Q4 2025, Q3 2025, and Q2 2025 respectively.